Masimo (MASI)
(Delayed Data from NSDQ)
$139.94 USD
+4.27 (3.15%)
Updated Oct 8, 2024 04:00 PM ET
After-Market: $140.00 +0.06 (0.04%) 7:58 PM ET
2-Buy of 5 2
C Value A Growth B Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$139.94 USD
+4.27 (3.15%)
Updated Oct 8, 2024 04:00 PM ET
After-Market: $140.00 +0.06 (0.04%) 7:58 PM ET
2-Buy of 5 2
C Value A Growth B Momentum A VGM
Zacks News
The Zacks Analyst Blog Highlights: Cardinal Health, Penumbra, STAAR Surgical, Masimo and Smith & Nephew
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Cardinal Health, Penumbra, STAAR Surgical, Masimo and Smith & Nephew
Top MedTech Stocks Safe from Graham-Cassidy Repeal Bill
by Zacks Equity Research
The investment climate for medical device majors has become increasingly volatile due to political potshots in Capitol Hill, for and against Obamacare.
Republicans Take Last Shot at Obamacare: 5 MedTech Stocks to Buy
by Zacks Equity Research
The fate of Obamacare will be decided on Sep. 30. No matter what the future holds, the day will provide investors a clear picture of where the MedTech industry is headed.
Masimo (MASI) Launches Rad-97 CO-Oximeter Post FDA Clearance
by Zacks Equity Research
Masimo's (MASI) newly-launched Rad-97 Pulse CO-Oximeter will strengthen the company's presence in the Advanced Monitoring Technologies space.
5 Discounted MedTech Stocks for a Healthy Portfolio
by Zacks Equity Research
In view of the current political scenario and banking on favorable metrics, these five MedTech stocks stand out as the most suitable value picks.
Why Is Masimo (MASI) Down 1.5% Since the Last Earnings Report?
by Zacks Equity Research
Masimo (MASI) reported earnings about a month ago. What's next for the stock? We take a look at earnings estimates for some clues.
Ride Out MedTech Volatility With These 3 Ultra-Safe Stocks
by Zacks Equity Research
In view of the current political scenario and banking on favorable metrics, these three low-beta MedTech stocks stand out as the most suitable value picks.
3 Excellent Value Picks as Political Chaos Grips MedTech
by Zacks Equity Research
In view of the current political scenario and banking on favorable metrics, these three MedTech stocks stand out as the most suitable value picks.
Zacks.com featured highlights: CBRE Group, East West Bancorp, Hasbro, Canadian Pacific Railway and Masimo
by Zacks Equity Research
Zacks.com featured highlights: CBRE Group, East West Bancorp, Hasbro, Canadian Pacific Railway and Masimo
5 GARP Stocks to Buy for Marvelous Returns
by Zacks Equity Research
GARP helps an investor gain exposure to stocks that are undervalued and have impressive prospects.
Here's Why Chemed (CHE) is a Suitable Growth Pick for Now
by Zacks Equity Research
Banking on favorable Net Margin and ROE, Chemed (CHE) stands out as one of the most suitable growth stocks.
IDEXX Laboratories (IDXX), Great Growth Pick: Here's Why
by Zacks Equity Research
Banking on a number of favorable metrics, IDEXX Laboratories (IDXX) stands out as one of the most suitable growth stock.
Is Amedisys (AMED) a Great Value Stock for Your Portfolio?
by Zacks Equity Research
Banking on a number of favorable metrics, Amedisys (AMED) stands out as one of the most suitable value stock.
Here's Why Masimo (MASI) is a Suitable Value Pick for Now
by Zacks Equity Research
Masimo (MASI) seems to be a solid value pick with favorable P/E ratio and P/FCF ratio compared with its broader industry.
McKesson Banks on Distribution Business Amid Pricing Woes
by Zacks Equity Research
McKesson (MCK) entered fiscal 2018 with an assumption of branded inflation in the mid-single digits. Pricing pressure in the independent retail pharmacy channel is a headwind.
BioTelemetry Hits a 52-Week High: What's Driving the Stock?
by Zacks Equity Research
BioTelemetry (BEAT) is putting efforts in product innovation through research and development. The company recently announced the acquisition of LifeWatch AG in a deal valued at about $280 million.
Masimo (MASI) Introduces SafetyNet System in Dubai Hospitals
by Zacks Equity Research
Masimo's (MASI) proprietary Patient SafetyNet system's introduction in the Dubai market is in line with its strategy of becoming the dominant player in the pulse oximetry market.
Zacks.com featured highlights: CBRE Group, Canadian Pacific Railway, East West Bancorp, Hasbro and Masimo
by Zacks Equity Research
Zacks.com featured highlights: CBRE Group, Canadian Pacific Railway, East West Bancorp, Hasbro and Masimo
Top 5 GARP Stocks to Scoop Up Right Now
by Zacks Equity Research
The GARP approach prefers stocks that are priced below the market or any reasonable target determined by fundamental analysis.
Masimo (MASI) Beats on Q2 Earnings and Revenues, Guides Up
by Zacks Equity Research
Masimo's (MASI) stable performance across its businesses was the key highlight of second quarter.
MedTech Stock Earnings Slated for Aug 2: CAH, HOLX & More
by Zacks Equity Research
Despite solid strategic initiatives, the ongoing political conundrum at the Capitol Hill is likely to affect earnings results of these four major Medical Technology bigwigs.
Masimo (MASI) Rainbow Super DCI-mini Sensor Now CE Marked
by Zacks Equity Research
Irvine, CA-based Masimo Corporation (MASI) recently announced the receipt of CE mark for the noninvasive and reusable rainbow Super DCI-mini sensor.
Masimo (MASI) Presents Utility Study of Oxygen Reserve Index
by Zacks Equity Research
Masimo Corporation (MASI) recently announced data from its study evaluating the potential clinical utility of Masimo Oxygen Reserve Index.
Zacks.com featured highlights: 58.com, RPC, U.S. Silica Holdings, Masimo and Manitowoc
by Zacks Equity Research
Zacks.com featured highlights: 58.com, RPC, U.S. Silica Holdings, Masimo and Manitowoc
5 Stocks to Watch for Accelerating Earnings Growth
by Tirthankar Chakraborty
Earnings acceleration should be viewed as a key metric for share price outperformance